Customer Publication

Croft et all roughness

Digital Holographic Imaging as a Method for Quantitative, Live Cell Imaging of Drug Response to Novel Targeted Cancer Therapies

Authors: L. Croft et al.

Journal: Theranostics: Methods and Protocols (2019)

Institution: Queensland University of Technology

Research Areas: Cancer research

Cell Lines: HeLa (Human cervical cancer cell line)

Summary: L. Croft with co-authors have prepared a protocol on how to evaluate cancer drug affects by using non-invasing digital holographic imaging, i.e. HoloMonitor M4. Authors describe the use of the DHI platform HoloMonitorM4 to evaluate the effects of novel, targeted cancer therapies on cell viability and proliferation using the HeLa cancer cell line as a model. They present single cell tracking and population-wide analysis of multiple cell morphology parameters.

Keywords: HoloMonitor M4, cell proliferation, cell morphology

Read the article …

Phase Holographic Imaging PHI AB
Skiffervägen 48
224 78 Lund
+46 46 38 60 80

Phase Holographic Imaging PHI Inc.
265 Franklin Street Suite 1702
Boston, MA 02110
+1 617-963-5150


VAT: SE556542781101

Securities Identification

ISIN: SE0005504636
LEI: 549300JZR79QYESM6296

HoloMonitor® is a registered trademark
Copyright © 2012-2021
Phase Holographic Imaging PHI AB

Phase Holographic Image logo in white

PHI Theme 3.12.2